Thursday , October 13 2016
Home / News / India / Nadda inaugurates CGMP compliant facility for production of vaccines

Nadda inaugurates CGMP compliant facility for production of vaccines


Kasauli (Himachal Pradesh): Union Minister for Health and Family Welfare J P Nadda inaugurated the first of its kind Current Good Manufacturing Practise (CGMP) compliant facility for manufacture of DPT and TT vaccine at the Central Research Institute (CRI), here today.
He announced functioning of the zonal office of CDSCO from the Container Corporation of India building, Baddi to facilitate Pharma companies and exporters from Himachal Pradesh, Punjab and Haryana to get their clearances and no objection certificates.

This office will start working within a week, he said.

He added that the Himachal Pradesh government has agreed to provide land for the Zonal Office of CDSCO at Baddi.

The Minister also announced that in order to ensure production of quality medicines, three to four comprehensive workshops will be organized in May in Baddi on good manufacturing practices and good laboratory practices. Best experts from national and international regulators will be there to brief the industry on related issues.

The Health Minister congratulated the institute and stated that this is a milestone in the vaccine production capacity of the country, and CRI as it gets ready to celebrate its 111th foundation day the coming month.

Nadda further noted that recent advancements in regulatory requirements and introduction of CGMP concept in vaccine manufacturing led to the need for creation of CGMP compliant infrastructure and processes. Considering this, CRI has been able to create this CGMP compliant facility for production of DPT group of vaccines with the guidance and support of the Ministry of Health and Family Welfare.

The Health Minister also launched the website of CRI at the occasion.

Central Research Institute, Kasauli is one of the most important suppliers of vaccines for the Government’s Universal immunization programme (UIP) especially for DPT and TT vaccines. The Institute is involved in manufacture and supply of various lifesaving therapeutic antisera for snake bites, Rabies and Diphtheria, and supplies Yellow Fever Vaccine to different parts of the country. Diagnostic reagents such as diagnostic antigens for typhoid, typhus fever and brucellosis and diagnostic antisera for cholera and salmonella are also manufactured and supplied to various Institutions throughout the country. (ANI)

Read Also


Paracyclist forced to remove prosthetic: Deepa Malik for better technology